RxDoctor Payments Data

John Najjar, MD

Vascular Surgery · Worcester, MANPI 1487630935

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 39.7% of the total. Reporting peaked in 2023 at $2,795 and has fallen 77.0% since, to $642 in 2025.

$9,610in general payments, 2019–2025

Across 135 payments — averaging $71.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Cordis US CORP.$2K
  • Silk Road Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • Endologix LLC$628
  • Abiomed$137
  • plus $898 from 15 others

What the payments were for

  • Consulting fees$1,80019%
  • Travel & lodging$2,50526%
  • Food & beverage$5,30555%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,610 in reported general payments places this provider in the 70th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$109,415
Medicare patients
663
Services billed
1,142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban72$59,427
XareltoRivaroxaban31$26,805
Cilostazol134$5,400
ClopidogrelClopidogrel Bisulfate212$5,049
Nifedipine ErNifedipine26$706
Pantoprazole Sodium30$378
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$192
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen19$88

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →